Two extraordinary papers by colleagues in Leeds definitively answer this question at last! Using APTIMA COMBO 2 (AC2) for Chlamydiathe first paper 1 concludes 'the optimum sample for chlamydia screening in women without symptoms is a self-taken vulvovaginal swab. Even in women with symptoms suggestive of an infection, a vulvovaginal swab is superior to endocervical sampling for chlamydia detection. In those women with symptoms, using endocervical rather than vulvovaginal swabs would have missed 9% of infections, or 1 in every 11 cases of chlamydia'.
The second paper 2 looked at gonorrhoea and both self-taken or endocervical AC2 swabs were superior to culture. Sensitivity was 99% for vulvovaginal swabs and 96% for endocervical swabs using AC2. Almost 4000 women were enrolled in this study and the results confirm what many of us have suspected, i.e. a cleanly, well-taken endocervical swab can miss urethral chlamydia so, in effect, the messier the swab, the better! With immediate effect, we changed our clinic protocol to ensure that all women being tested with AC2 had a vulvovaginal swab sent. Even in patients with symptoms who were being examined with a speculum, the physician was instructed to take a vestibular and vulvovaginal swab before inserting a speculum for further swabs for gram stain, wet prep, etc.
This also means that patients who have a self-taken AC2 swab done in General Practice or Community Clinics, can be reassured that they have had the best possible investigation, as some patients mistakenly think that a speculum-based examination is essential for a 'proper' screen.
Any GUM clinics, therefore, using AC2 tests should ensure that a vulvovaginal AC2 swab is always sent instead of a precisely-taken endocervical.
